Parameters | Groups | Mean ± SD | ||
duration of diabetes (Years) | T2DM with neuropathy | 14.85 ± 5.032 | ||
T2DM without neuropathy | 14.74 ± 4.15 | |||
HbAlc (%) | T2DM with neuropathy | 8.4 ± 1.2 | ||
T2DM without neuropathy | 8.1 ± 1.6 | |||
Retinopathy | T2DM with neuropathy | Background | 52/75 (69.33%) | |
Proliferative | 21/75 (28%) | |||
T2DM without neuropathy | Background | 18/100 (18%) | ||
Proliferative | 4/100 (4%) | |||
Creatinine (mg/dl) | T2DM with neuropathy | 1.2 ± 0.9 | ||
T2DM without neuropathy | 0.8 ± 0.2 | |||
Cholesterol (mg/dl) | T2DM with neuropathy | 210.22 ± 69.16 | ||
T2DM without neuropathy | 155 ± 44.32 | |||
Triglyceride (TG, mg/dl) | T2DM with neuropathy | 140.97 ± 88.60 | ||
T2DM without neuropathy | 133 ± 45.23 | |||
Blood Pressure | T2DM with neuropathy | Mild hypertension | 35 (45.9%) | |
Moderate hypertension | 28 (37.9%) | |||
Severe hypertension | 8 (10.8%) | |||
Normal | 4 (5.4%) | |||
T2DM without neuropathy | Mild hypertension | 31 (31%) | ||
Moderate hypertension | 23 (23%) | |||
Severe hypertension | 9 (9%) | |||
Normal | 37 (37%) | |||
High density lipoprotein (HDL, mg/dl) | T2DM with neuropathy | 39.14±12.67 | ||
T2DM without neuropathy | 42.11 ± 6.32 | |||
Low density lipoprotein (LDL, mg/dl) | T2DM with neuropathy | 144.35 ± 63.21 | ||
T2DM without neuropathy | 111.24 ± 24.105 | |||
Microalbuminuria/ Macroalbuminuria | T2DM with neuropathy | 20/42 | ||
T2DM without neuropathy | - | |||